A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitisKathleen Machiels, Séverine Vermeire, Marc Ferrante et al.|Gut|2013Cited by 1.9k
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel diseaseBram Verstockt, Marc Ferrante, Sare Verstockt et al.|EBioMedicine|2019Cited by 173
Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype EquilibriumBrecht Creyns, Christine Breynaert, Inge Jacobs et al.|Frontiers in Immunology|2020Cited by 40
Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological MaterialsIsabelle Cleynen, Nadine Ectors, Loes Linsen et al.|Frontiers in Medicine|2019Cited by 5
P601 Development and validation of dried blood spot sampling as a tool to identify the best time point to measure predictive ustekinumab serum concentrations in patients with Crohn’s diseaseNathalie Van den Berghe, Debby Thomas, Eline Vandeput et al.|Journal of Crohn s and Colitis|2020Cited by 3